Skip to main content
SpringerLink
Log in

Prognostic Performance of Myocardial Perfusion and Function

  • Chapter
  • First Online:
Atlas of Nuclear Cardiology

  • 809 Accesses

Abstract

Since its beginnings in the early 1970s, clinical nuclear cardiology has evolved substantially, gaining both technical sophistication and enhanced imaging capabilities. In parallel to these developments, an extensive literature supporting its clinical utility and cost-effectiveness has developed. Current single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) allows for objective measurement of myocardial function and relative regional myocardial perfusion at rest and stress, providing accurate risk assessment in a wider variety of patient populations. The evidence for similar prognostic data derived from positron emission tomography (PET) is rapidly growing. This chapter highlights the prognostic utility of these two modalities and illustrates how this information can guide patient management decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44–e164.

    Article  PubMed  Google Scholar 

  2. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al.; COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91.

    Google Scholar 

  3. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.

    Article  PubMed  Google Scholar 

  4. ISCHEMIA Trial Research Group, Maron DJ, Hochman JS, O’Brien SM, Reynolds HR, Boden WE, Stone GW, et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: rationale and design. Am Heart J. 2018;201:124–35.

    Article  PubMed Central  Google Scholar 

  5. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al.; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.

    Google Scholar 

  6. Phillips LM, Hachamovitch R, Berman DS, Iskandrian AE, Min JK, Picard MH, et al. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol. 2013;20:969–75.

    Article  PubMed  PubMed Central  Google Scholar 

  7. BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.

    Article  Google Scholar 

  8. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390–5.

    Article  CAS  PubMed  Google Scholar 

  9. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7:464–71.

    Article  CAS  PubMed  Google Scholar 

  10. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11:414–23.

    Article  PubMed  Google Scholar 

  11. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 1993;22:1455–64.

    Article  CAS  PubMed  Google Scholar 

  12. Garcia EV. Quantitative myocardial perfusion single-photon emission computed tomographic imaging: quo vadis? (Where do we go from here?). J Nucl Cardiol. 1994;1:83–93.

    Article  CAS  PubMed  Google Scholar 

  13. Sharir T, Germano G, Waechter PB, Kavanagh PB, Areeda JS, Gerlach J, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. II: validation and diagnostic yield. J Nucl Med. 2000;41:720–7.

    CAS  PubMed  Google Scholar 

  14. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med. 2000;41:712–9.

    CAS  PubMed  Google Scholar 

  15. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–42.

    Article  PubMed  Google Scholar 

  16. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535–43.

    Article  CAS  PubMed  Google Scholar 

  17. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol. 2005;12:66–77.

    Article  PubMed  Google Scholar 

  18. Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol. 1996;27:1612–20.

    Article  CAS  PubMed  Google Scholar 

  19. Berman DS, Kang X, Gransar H, Gerlach J, Friedman JD, Hayes SW, et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol. 2009;16:45–53.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Xu Y, Hayes S, Ali I, Ruddy TD, Wells RG, Berman DS, et al. Automatic and visual reproducibility of perfusion and function measures for myocardial perfusion SPECT. J Nucl Cardiol. 2010;17:1050–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Xu Y, Nakazato R, Hayes S, Hachamovitch R, Cheng VY, Gransar H, et al. Prognostic value of automated vs visual analysis for adenosine stress myocardial perfusion SPECT in patients without prior coronary artery disease: a case-control study. J Nucl Cardiol. 2011;18:1003–14.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Motwani M, Leslie WD, Goertzen AL, Otaki Y, Germano G, Berman DS, Slomka PJ. Fully automated analysis of attenuation-corrected SPECT for the long-term prediction of acute myocardial infarction. J Nucl Cardiol. 2018;25:1353–60.

    Article  PubMed  Google Scholar 

  23. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013;61:176–84.

    Article  PubMed  Google Scholar 

  24. Sharir T, Berman DS, Lewin HC, Friedman JD, Cohen I, Miranda R, et al. Incremental prognostic value of rest-redistribution (201)Tl single-photon emission computed tomography. Circulation. 1999;100:1964–70.

    Article  CAS  PubMed  Google Scholar 

  25. Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol. 1987;9:752–9.

    Article  CAS  PubMed  Google Scholar 

  26. Sharir T, Bacher-Stier C, Dhar S, Lewin HC, Miranda R, Friedman JD, et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol. 2000;86:1171–5.

    Article  CAS  PubMed  Google Scholar 

  27. Matzer L, Kiat H, Van Train K, Germano G, Papanicolaou M, Silagan G, et al. Quantitative severity of stress thallium-201 myocardial perfusion single-photon emission computed tomography defects in one-vessel coronary artery disease. Am J Cardiol. 1993;72:273–9.

    Article  CAS  PubMed  Google Scholar 

  28. Ladenheim ML, Kotler TS, Pollock BH, Berman DS, Diamond GA. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol. 1987;59:270–7.

    Article  CAS  PubMed  Google Scholar 

  29. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995;26:639–47.

    Article  CAS  PubMed  Google Scholar 

  30. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905–14.

    Article  CAS  PubMed  Google Scholar 

  31. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;100:2140–5.

    Article  CAS  PubMed  Google Scholar 

  32. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol. 1999;33:661–9.

    Article  CAS  PubMed  Google Scholar 

  33. Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:1494–504.

    Article  PubMed  Google Scholar 

  34. Budoff MJ, Yang TP, Shavelle RM, Lamont DH, Brundage BH. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol. 2002;39:408–12.

    Article  PubMed  Google Scholar 

  35. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T; J-ACCESS Investigators. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J. 2008;72:611–7.

    Google Scholar 

  36. Zellweger MJ, Hachamovitch R, Kang X, Hayes SW, Friedman JD, Germano G, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004;25:543–50.

    Article  PubMed  Google Scholar 

  37. Nudi F, Biondi-Zoccai G, Schillaci O, di Belardino N, Versaci F, Nudi A, et al. Prognostic accuracy of myocardial perfusion imaging in octogenarians. J Nucl Cardiol. 2018;25:1342–9.

    Article  PubMed  Google Scholar 

  38. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.

    Article  PubMed  Google Scholar 

  39. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105:32–40.

    Article  PubMed  Google Scholar 

  40. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al.; Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.

    Google Scholar 

  41. Ahmed AM, Qureshi WT, O’Neal WT, Khalid F, Al-Mallah MH. Incremental prognostic value of SPECT-MPI in chronic kidney disease: a reclassification analysis. J Nucl Cardiol. 2018;25:1658–73.

    Article  PubMed  Google Scholar 

  42. Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging. 2009;2:429–36.

    Article  PubMed  Google Scholar 

  43. Rozanski A, Gransar H, Min JK, Hayes SW, Friedman JD, Thomson LE, Berman DS. Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol. 2014;21:341–50.

    Article  PubMed  Google Scholar 

  44. Abidov A, Hachamovitch R, Rozanski A, Hayes SW, Santos MM, Sciammarella MG, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 2004;44:1062–70.

    Article  PubMed  Google Scholar 

  45. Rozanski A, Gransar H, Hayes SW, Friedman JD, Hachamovitch R, Berman DS. Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. J Nucl Cardiol. 2010;17:999–1008.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551–61.

    Article  PubMed  Google Scholar 

  47. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol. 1995;26:1202–8.

    Article  CAS  PubMed  Google Scholar 

  48. Shaw L, Chaitman BR, Hilton TC, Stocke K, Younis LT, Caralis DG, et al. Prognostic value of dipyridamole thallium-201 imaging in elderly patients. J Am Coll Cardiol. 1992;19:1390–8.

    Article  CAS  PubMed  Google Scholar 

  49. Calnon DA, McGrath PD, Doss AL, Harrell FE Jr, Watson DD, Beller GA. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol. 2001;38:1511–7.

    Article  CAS  PubMed  Google Scholar 

  50. Amanullah AM, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol. 1996;27:803–9.

    Article  CAS  PubMed  Google Scholar 

  51. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol. 2005;45:722–9.

    Article  PubMed  Google Scholar 

  52. Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, Berman DS. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013;61:1054–65.

    Article  PubMed  Google Scholar 

  53. Duvall WL, Rai M, Ahlberg AW, O’Sullivan DM, Henzlova MJ. A multi-center assessment of the temporal trends in myocardial perfusion imaging. J Nucl Cardiol. 2015;22:539–51.

    Article  PubMed  Google Scholar 

  54. Abidov A, Hachamovitch R, Hayes SW, Ng CK, Cohen I, Friedman JD, et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation. 2003;107:2894–9.

    Article  PubMed  Google Scholar 

  55. Azarbal B, Hayes SW, Lewin HC, Hachamovitch R, Cohen I, Berman DS. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: superiority over 85% of maximal age-predicted heart rate. J Am Coll Cardiol. 2004;44:423–30.

    Article  PubMed  Google Scholar 

  56. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831–7.

    CAS  PubMed  Google Scholar 

  57. Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol. 2003;42:1818–25.

    Article  PubMed  Google Scholar 

  58. Alama M, Labos C, Emery H, Iwanochko RM, Freeman M, Husain M, Lee DS. Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: a systematic review and meta-analysis. J Nucl Cardiol. 2018;25:724–37.

    Article  PubMed  Google Scholar 

  59. Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14:521–8.

    Article  PubMed  Google Scholar 

  60. Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014;55:248–55.

    Article  PubMed  Google Scholar 

  61. Murthy VL, Lee BC, Sitek A, Naya M, Moody J, Polavarapu V, et al. Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb PET. J Nucl Med. 2014;55:1952–8.

    Article  CAS  PubMed  Google Scholar 

  62. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740–8.

    Article  PubMed  Google Scholar 

  63. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–24.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19–27.

    Article  PubMed  Google Scholar 

  65. Betancur J, Otaki Y, Motwani M, Fish MB, Lemley M, Dey D, et al. Prognostic value of combined clinical and myocardial perfusion imaging data using machine learning. JACC Cardiovasc Imaging. 2018;11:1000–9.

    Article  PubMed  Google Scholar 

  66. Chang SM, Nabi F, Xu J, Raza U, Mahmarian JJ. Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol. 2010;55:221–30.

    Article  PubMed  Google Scholar 

  67. Einstein AJ, Blankstein R, Andrews H, Fish M, Padgett R, Hayes SW, et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: the MILLISIEVERT study. J Nucl Med. 2014;55:1430–7.

    Article  CAS  PubMed  Google Scholar 

  68. Nakazato R, Berman DS, Hayes SW, Fish M, Padgett R, Xu Y, et al. Myocardial perfusion imaging with a solid-state camera: simulation of a very low dose imaging protocol. J Nucl Med. 2013;54:373–9.

    Article  CAS  PubMed  Google Scholar 

  69. Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S, Berman DS. High-speed myocardial perfusion imaging initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging. 2008;1:156–63.

    Article  PubMed  Google Scholar 

  70. Songy B, Guernou M, Hivoux D, Attias D, Lussato D, Queneau M, et al. Prognostic value of one millisievert exercise myocardial perfusion imaging in patients without known coronary artery disease. J Nucl Cardiol. 2018;25:120–30.

    Article  PubMed  Google Scholar 

  71. Lima R, Peclat T, Soares T, Ferreira C, Souza AC, Camargo G. Comparison of the prognostic value of myocardial perfusion imaging using a CZT-SPECT camera with a conventional Anger camera. J Nucl Cardiol. 2017;24:245–51.

    Article  PubMed  Google Scholar 

  72. Engbers EM, Timmer JR, Ottervanger JP, Mouden M, Knollema S, Jager PL. Prognostic value of coronary artery calcium scoring in addition to single-photon emission computed tomographic myocardial perfusion imaging in symptomatic patients. Circ Cardiovasc Imaging. 2016;9(5). pii:e003966.

    Google Scholar 

  73. Bybee KA, Lee J, Markiewicz R, Longmore R, McGhie AI, O’Keefe JH, et al. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol. 2010;17:188–96.

    Article  PubMed  Google Scholar 

  74. SCOT-HEART Investigators, Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379:924–33.

    Article  Google Scholar 

  75. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Kang X, Germano G, Berman DS. Is there a referral bias against catheterization of patients with reduced left ventricular ejection fraction? Influence of ejection fraction and inducible ischemia on post-single-photon emission computed tomography management of patients without a history of coronary artery disease. J Am Coll Cardiol. 2003;42:1286–94.

    Article  PubMed  Google Scholar 

  76. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32:1012–24.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant to Dr. Berman from the Miriam and Sheldon A. Adelson Medical Research Foundation and to Dr. Miller from the Arthur J E Child Fellowship grant.

Author information

Authors and Affiliations

  1. Department of Nuclear Cardiology, Leon H. Charney Division of Cardiology, New York University Langone Health, New York, NY, USA

    Lawrence M. Phillips

  2. Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Robert J. H. Miller

  3. Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA

    Leslee J. Shaw

  4. Department of Cardiovascular Medicine, Section of Cardiovascular Imaging, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

    Rory Hachamovitch

  5. David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

    Guido Germano

  6. Center for Equity of Care, Northwell Health, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA

    Jennifer H. Mieres

  7. S. Mark Taper Foundation Imaging Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Daniel S. Berman

Authors
  1. Lawrence M. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. H. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leslee J. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rory Hachamovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guido Germano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer H. Mieres
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniel S. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel S. Berman .

Editor information

Editors and Affiliations

  1. University of Maryland School of Medicine, Baltimore, MD, USA

    Vasken Dilsizian

  2. Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Jagat Narula

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Phillips, L.M. et al. (2021). Prognostic Performance of Myocardial Perfusion and Function. In: Dilsizian, V., Narula, J. (eds) Atlas of Nuclear Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-49885-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-49885-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-49884-9

  • Online ISBN: 978-3-030-49885-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation